Effects of Sarcopenia on General Health Status in Elderly: a Population-based Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

274 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-05-14

Study Completion Date

2023-02-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a observational study, that aimed to determine the prevalence of sarcopenia using European Wording Group on Sarcopenia in Older People (EWGSOP) algorithm in a general elderly population in Algarve region (Portugal). Because muscle is metabolically active tissue, sarcopenia may also contribute to the development of some of the metabolic disorders associated with aging. However, the risk factors associated with sarcopenia are poorly understood. Thus, a cross-sectional survey of a sample of 274 elderly adults aged 60 or over, were included in the study. Correlations of sarcopenia with functional level, lipid and glycemic profile, nutritional and physical activity level, fall risk, quality of life, and self-reported comorbidities will be studied.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of Physical Performance in Old Adults With Sarcopenic Obesity

NCT06299241

Obesity Sarcopenia

COMPLETED

Evaluation of Sarcopenia With SARC-F and Anthropometric Measurement

NCT05241886

Sarcopenia Older People

COMPLETED

Sarcopenic Obesity: Estimation of Prevalence and Identification of Clinical and Biological Determinants in a Population of Adult Obese Patients

NCT03394469

Obesity

UNKNOWN NA

Evaluation of the SARC-F Score as a Screening Tool for Undernutrition in a Geriatric Population

NCT03553147

Sarcopenia Denutrition

UNKNOWN NA

Slow Gait Speed as an Indicator of Overweight, Dynapenic Obesity and Sarcopenic Obesity in Elderly People in the Community

NCT06413030

Frailty Obesity Sarcopenia +2 more

ENROLLING_BY_INVITATION

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sarcopenia Sarcopenic Obesity Frailty

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Elderly

Group of 274 elderly

Sarcopenia Assessment

Intervention Type OTHER

The prevalence of sarcopenia in a group of elderly people and its correlation with other health variables was determined.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sarcopenia Assessment

The prevalence of sarcopenia in a group of elderly people and its correlation with other health variables was determined.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Minimum age of 60 years;
* Live in the community;
* Independet Gait.

Exclusion Criteria

* Presence of moderate or severe cognitive impairment;
* Presence of uncontrolled cardiovascular disease and active cancer;
* Use of a pacemaker;
* Use of internal prosthesis.

Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes